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Summary. The group of brain tumors with mature 
components encompasses severa1 pathological entities 
including: the ganglioneuroma; the gangliocytoma; the 
ganglioglioma; the desmoplastic ganglioglioma; the 
neurocitoma and a group of glioneuronal hamartomatous 
tumorous lesions, such as meningoangiomatosis. The 
dysembryoplastic neuroepithelial tumor is characterized 
by the presence of multiple cortical nodules made up of 
small, oligo-like cells and a myxoid pattern rich in 
mucopolysaccharides. Mature neuronal cells are 
frequently detected throughout the tumor. Most of them 
are associated with microhamartias in the adjacent brain 
and pharmacoresistant epilepsy. The excellent prognosis 
of the majority of these tumors and the potential for 
malignant transformation of the glial component in the 
ganglioglioma are the two most remarkable findings. 
Histological signs of anaplasia and greater mitotic and 
proliferative activities are associated with local 
recurrences. Atypical neurocytomas occur only 
exceptionally. Treatment choices are surgical 
resectioning and, in those cases presenting greater 
proliferative activity and cytological atypia, 
postoperative radiotherapy rnay be recornmended. 
This paper reviews this heterogeneous group of 
neoplasms and hamartomatous lesions, pointing out 
presumable transitions among the different types of 
mixed neuronal and glial brain tumors. A single term of 
"mixed neuronal-glial tumors" is defended, 
distinguishing different subgroups of tumors, depending 
on the predominant cellular component. 
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lntroduction 
Brain tumors comprised of mature or immature 
neuronal cells and associated with a mixed neural and 
glial component are very rare, constituting roughly 1% 
to 3% of adult brain tumors (Wolf et al., 1993; Hakim et 
al., 1997), and about 10% of those occurring in children 
(Chintagumpala et al., 1996). This group encompasses 
the ganglioneuroma, the gangliocytoma, the 
ganglioglioma, the desmoplastic ganglioglioma, the 
ganglioneuroblastoma, the neurocytoma and 
dysembryoplastic neuroepithelial tumors, in addition to a 
series of lesions or tumors of a presumably 
hamartomatous nature. Other tumors that rnay be 
histogenetically related are the pleomorphic 
xanthoastrocytoma, which presents neuronal 
differentiation, and tumors associated with 
neurofibromatosis. They are mostly located at the 
supratentorial level, follow a benign course, and are 
associated with a long history of drug-resistant epilepsy 
(Fingarella-Branger et al., 1992; Armstrong, 1993; 
Daumas-Duport, 1993; Wolf et al., 1993, 1994; 
Chintangupala et al., 1996; Hakim et al., 1997). These 
lesions are often detected during the first decades of life, 
although they have been reported to occur at any age. 
The mean 5-year survival is over 80% in the majority of 
the series described in the literature (Schild et al., 1997). 
Epilepsy is relatively frequently associated with 
brain tumors (Ketz, 1974; Morris and Estes, 1993). 
However, tumors rnay or rnay not cause epilepsy, even 
when they are of the same type and located in the same 
brain area. Thus, tumors are not intrinsically 
epileptogenic. Furthermore, seizure activity associated 
with brain tumors rnay develop relatively soon or after 
severa1 years (Ketz, 1974; Spencer et al., 1984; Morrel, 
1989; Morris and Estes, 1993). Therefore, it is thought 
that in the pentumoral cortex occurs a series of changes 
that eventually rnay lead to epilepsy occurs. 
Detailed microanatomical and neurochemical studies 
of the peritumoral cortex temporal lobe epileptic patients 
presenting a variety of tumors have shown a decrease 
inhibitory GABAergic interneurons (Haglund et al., 
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1992; Marco et al., 1996, 1997). Among the inhibitory 
intemeurons that are lost, chandelier cells appear to be 
one of the most affected neurons (Marco et al., 1996, 
1997). Since chandelier cell axons are virtually the only 
source of inhibitory synapses on pyramidal cell axon 
initial segments, and this region of the pyramidal cell 
appears to be strategically important for the control of 
pyramidal cell excitability, chandelier cells are 
considered to be the most powerful cortical inhibitory 
interneuron (De Felipe, 1999). On the other hand, 
pyramidal cells are the main source of cortical efferent 
axons and of intracortical collaterals and, consequently, 
they are responsible for the spread of epileptiform 
activity. Thus, the loss of chandelier cells has been 
suggested to play a crucial role in the development of 
epilepsy (De Felipe, 1999). 
General histological features 
Although most of these lesions or tumors are located 
in the temporal lobe, they have been detected throughout 
the neuroaxis, including the spinal cord. Macro- 
scopically, ganglionic tumors can be solitary or multiple, 
solid or cystic. They are usual1 well circumscribed and 
the diameter varies. Generally, they present calcifications 
and may involve the subarachnoid space. The pediatric 
desmoplastic ganglioglioma is typically identified as a, 
massive tumor, while the dysembryoplastic tumor is 
small, barely measuring a few millimeters, and 
circumscribed, corresponding to multiple superficial 
cortical nodules of 0.5 to 3 mm in diameter (Ng et al., 
1990; Daumas-Duport, 1993). Hamartias are usually 
microscopic lesions, and hamartomas can measure 
several mm (Wolf et al., 1994). 
At the histological level, this group of tumors is 
basically made up of: (a) mature gangliocytic neuronal 
cells with abundant cytoplasm, vesicular nuclei and 
prominent nucleoli, usually arranged in groups, and 
scattered binucleated neurons are often present; (b) 
small, mature neuronal cells, with or without projections, 
with a small amount of pale or slightly eosinophilic 
cytoplasm; (c) astrocytic and oligodendroglial glial cells; 
(d) lymphocytes at the perivascular level; (e) fibrillar 
stroma, similar to the neuropil, in those lesions 
presenting a neuronal component; (f) loose, myxoid 
stroma with occasional cysts, a characteristic of the 
dysembryoplastic neuroepithelial tumors; (g) 
cytoarchitectural changes in the adjacent cortex, with 
neuronal, dysgenetic clusters (abnormal numbers and 
arrangements of neurons); (h) conspicuous eosinophilic 
Flg. 1. a. Gtbnwmnal hamarrks. leeion k mposed of ckwrnscribed rnicroscopic amregates of dborganlzed rnature neuronal and glial 
elernmw. b. An =ea of oortex with mwited cMtlcel dbwgankatlon, gliosk, neuronal loss and rnicrocalclfscaüons. Hematoxylin-eosin, x 250 
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protein droplets and spherical structures known as  
granular bodies; and (i) calcifications. 
Ultrastructural and immunophenotypic features 
Light microscope studies of these tumors must 
frequently be complemented by ultrastructural and 
immunohistochemical studies to determine the tumor 
phenotype. The ultrastructural characteristics of neuronal 
cells include dense core granules, cell processes with 
microtubules and synapses associated with clear 
vesicles. Astrocyte cells contain abundant intermediate 
filaments. 
According to immunophenotypic analysis, the 
neuronal component expresses markers for a particular 
cellular strain, as well as neurofilaments (NFP-H/m 
epitopes), synaptophysin, class 111 beta-tubulin, MAP 2 
and some neuropeptides (neuropeptide Y, met- 
enkephalin, beta-endorphin, substance P, somatostatin, 
etc) in almost 100% of cases (chromogranin A in 80% to 
90% of tumors); it also expresses the adhesion molecule 
E-NCAM, an embryonic form of the neuronal cell 
adhesion molecule, which is positive in many dysplastic 
neurons, in glioneuronal hamartias and in central 
neurocytoma. Conversely, the cells in dysembryoplastic 
neuroepithelial tumors are mostly negative for E-NCAM 
(Wolf et al., 1995). Regional neuronal markers, such as 
calbindin D-28K, expressed in Purkinje cells, can be 
detected in those tumors arising in the cerebelium. 
Description of the different leslons 
The hamartoma is defined as a mass of disorganized, 
but mature, neurons and glial celis; despite its tumor-like 
gross appearance, it has no histological features of 
malignancy and no proliferative activity is observed. The 
glioneuronal harnartias are poorly circumscribed lesions 
with misplaced neuronal cells (Fig. la). They include 
areas of dysgenesis (foca1 cortical dysplasia, with groups 
of large bizarre neurons accompanied by glial cells 
throughout the cortex) and rnicrodysgenesis in the form of 
heterotopias, neuronal clustering and rows of perivascular 
giial cells (Fig. lb) (Volk and Prayson, 1997). 
The ganglioneuroma is composed exclusively of 
gangliocytic cells with occasional Schwann ceíls. Most 
frequently, it arises in association with the autonomous 
and peripheral nervous systems; the exceptions, reported 
in the central neuroaxis, are associated with ectopic 
peripheral neural tissue or peripheral nerve rmts (Lantos 
et al., 1997). 
The gangliocytoma represents less than 0.5% of 
brain tumors (Russell and Rubinstein, 1989). And is 
Flg. 2. Qangliogliomas. a. An exarnple of ganglioglioma wkh a d i s e  cell growth pattern and the characteristic vascular arborlzation. b. An exmple of 
desmoplastic ganglioglioma with neurons enmeshed In a wllagemnrs, retlculin-rich stroma. Hematoxylin-dn, x 350 
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composed of neuron-gangliocytic cells and a variable 
component of non-neoplastic astrocytes. In contrast to 
the ganglioglioma, it has a less common cystic 
component. Neurons usually have pleomorphism and 
bizarre forms. The hamartomatous or neoplastic nature 
of this lesion has been questioned (Lantos et al., 1997). 
Tumor recurrence after complete removal has been 
reported (Felix et al., 1994). 
The ganglioglioma is a tumor with a mixed glial and 
neuronal components (Figs. 2,3). It is the most common 
of the glioneuronal neoplasms, with an incidence 
ranging between 0.4% and 6.25% of primary brain 
tumors (Russell and Rubistein, 1989; Chintagumpala et 
al., 1996; Isimbaldi et al., 1996; Hakim et al., 1997; 
Lantos et al., 1997). It is generally located in the 
temporal lobe, although it has been observed in frontal 
lobe and at other sites. The mean patient age at diagnosis 
is 20 years, ranging from 1 to 80 years. There is a slight 
male predilection (Ng et al., 1990; Wolf et al., 1994; 
Chintagumpala et al., 1996; Isimbaldi et al., 1996; 
Hakim et al., 1997). The macroscopic aspect is generally 
cystic with a wall nodule. Microscopic study discloses a 
heterogeneous lesion, with different histological cell- 
growth patterns. The architectural pattern of this tumor 
varies from one case to another and even among the 
different portions of the lesion. It frequently assumes an 
alveolar arrangement, with a tree of narrow capillary 
vessels (Fig. 2a), and clustered neuronal cells that tend 
to present more mature forms in the central area (Figs. 
3a,b). Occasionally, there is a prominent desmoplastic 
reaction with abundant vessels both in the leptomeninges 
and at the cortical leve1 (Fig. 2b) or tumors with a 
predominant gangliocytic component (Fig. 4a). The glial 
component shows a variable cell density with areas 
similar to the common glial tumor, especially that of the 
pilocytic astrocytoma. Recently, a distinctive 
glioneuronal tumor with neuropil-like islands has been 
described (Fig. 4b). These islands were composed of 
oligodendrocyte-like elements "neurocytic" and well 
differentiated neurons (Teo et al., 1999). The 
ganglioglioma has anaplastic and malignant variants 
(Sasaki et al., 1996; Hakim et al., 1997). Moreover, 
composite pleomorphic xanthoastrocitoma (PXA) and 
ganglioglioma have been described (Perry et al., 1997). 
These authors describe three forms of association 
between PXA and GG, with some tumors displaying 
both neoplastic elements with minimal intermingling, 
others showing features of typical PXA with dysmorphic 
ganglion cells which express synaptophisin (SYN) 
immunoreactivity, and others presenting a composite of 
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PXA and GG arranged as in a "collision tumor". We 
have also observed tumors composed predominantly of 
typical GG but with abundant multinucleated cells 
dispersed among the glial and neuronal celis. These cells 
are immunoreactive for SYN and Glial Fibrilar Acidic 
Protein (GFAP) and in some areas were associated with 
a desmoplastic stroma or a pilocitic component of the 
GG. Those areas could represent incipient PXA (Fig. 5) 
arising in otherwise typical GG. 
The neurocytoma represents approximately 0.5% of 
intracranial tumors (Kim et al., 1997); the usual location 
is intraventricular, near the foramen of Monro. Most 
patients show symptoms of intracranial hypertension and 
the clinical history is usually short. This lesion is 
composed of small, mature neurons, fibrillar stroma and 
frequent calcifications (Fig. 6). It is easily confused with 
the oligodendroglioma. It presents no cytological atypias 
or significant mitotic activity (Fingerella-Branger et al., 
1992; Nishio et al., 1992; Tsuchida et al., 1996; Lantos 
et al., 1997). The existence of an extraventricular 
neoplasm with the features of the neurocytoma has 
recently been reported (Giangaspero et al., 1997). 
The dysembryoplastic neuroepithelial tumor is 
associated with chronic intractable seizure disorders and 
may represent up to 25% of al1 lesions removed to treat 
chronic drug-resistant epilepsy (Wolf et al., 1993, 1995; 
Raymond et al., 1995; Pasquier et al., 1996). It is 
characterized by the presence of multiple cortical 
nodules varying in diameter, with a gelatinous 
consistency and distended cortical ribbon. It is made up 
of small, oligo-like cells with scarce cytoplasm and a 
myxoid pattern rich in mucopolysaccharides (Fig. 7). 
Mature neuronal cells are frequently detected throughout 
the tumor (Armstrong, 1993; Daumas-Duport, 1993; 
Hirose et al., 1994). This lesion is also easily confused 
with the low-grade oligodendroglioma and astrocytoma 
and frequently there is adjacent cortical migration 
alterations. 
The presence of satellites in the adjacent cortex 
should be assessed an immunohistochemical study 
carried out to detect the neuronal component (Daumas- 
Duport, 1993; Hirose et al., 1994). In contrast to 
hamartias, the cellular elements do not express E-NCAM 
immunoreactivity (Wolf et al., 1995). 
Another malformative hamartomatous lesion that 
has a neuronal component is the so-called meningo- 
angiomatosis, which may present a cytological 
component comparable to that of the gangliocytoma. It 
is characterized by its prominent vascular pattern and 
fibrosis in the leptomeninges, which is extended 
throughout the Virchow-Robin spaces (Fig. 8) (Goates et 
al., 1991; Prayson, 1995). 
Flg. 4. Exarnples oí glioneuronal tumors with a predorninant component oí 
x400 
gangliooytlc cells (a) and a rossetold growth paltem @). Hernatoxyíin-eosin, 
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Most of these tumors or lesions arise within an 
underlying hamartomatous condition, including frequent 
dysplastic pathology in the adjacent cerebral cortex 
(Wolf et al., 1995; Lantos et al., 1997). Moreover, our 
findings in over 160 lesions associated with chronic 
epilepsy coincide with those of other studies involving 
lesions associated with drug-resistance epilepsy (Wolf et 
al., 1995; Alvarez et al., 1997) in suggesting presumable 
Flg. 5. An example of an xanthoastrocitrna pleomorphic showing numerous giant cells and a cellular background of glial cells and vety sparse 
gangliocyiic-like cells. Hematoxylin-eosin, x 300 
Flg. 6. Neurocytoma. The tumor is wmposed of 
small neurocytes in a fine fibrillar background. 
Hematoxylin-eosin, x400 
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transitions among the different types of neuronal brain 
tumors. In fact, we postulate that they may constitute a 
single tumor group with different subtypes, depending 
on the predominance of a mature or immature neuronal 
component,  on the glial cellularity or  on the 
accompanying fibrovascular stromal reaction. This 
unifying concept of glioneuronal tumors of the brain 
may explain recent reports concerning transitibnal forms 
of neuronal brain tumors and the divergent 
differentiation of these lesions (Powell et al., 1996; 
Yamamoto et al., 1996; Shimbo et al., 1997). In this 
context, there are some reports of tumors presenting 
features of the dysembryoplastic neuroepithelial tumor 
and the ganglioglioma (Shimbo et al., 1997), as well as 
of the neurocytoma and the gangliocytoma (Yamamoto 
et al., 1996) and other combinations. 
Prognostic criteria 
Most of the tumors or lesions associated to refractary 
epilepsi and presenting a neuronal component have an 
excellent prognosis, with a low incidence of recurrence 
andlor of malignant transformation. Such malignant 
transformation has been reported in up to 3% of 
gangliogliomas (Sasaki et al., 1996; Hakim et al., 1997) 
and, exceptionally, in the neurocytoma (Mrak, 1994; 
Yamamoto et al., 1996; Eng et al., 1997). Thus, it is 
important to identify this group of tumors, differentiating 
them from others with a more aggressive course that 
may require chemotherapy andlor radiotherapy. They are 
frequently confused with astrocytic glial tumors, with 
oligodendrogliomas and even with primary 
neuroectodermal tumors. Nevertheless, low-grade 
astrocytic tumors have been obsewed in association with 
chronic epilepsy and, recently, a distinctive group of 
astrocytic tumors has been reported to be associated with 
long-term epilepsy, with an excellent prognosis 
(Bartolomei et al., 1997). 
a) Biological criteria 
The location of the tumor itself is a prognostic factor 
related to its suitability for resection, which is the chosen 
treatment. Even the childhood desmoplastic 
ganglioglioma, which is detected before the child 
reaches the age of two and is very large in size, can have 
a favorable outcome if completely removed 
(VandenBerg et al., 1987; Ng et al., 1990). The detection 
of a neurocytoma or ganglioglioma in a patient over 50 
years of age is  associated with a worse prognosis 
Flg. 7. a and b. Dysembryoplastic neuroepithelial tumor. The intracortical r 
and a frequent target-like pattem. Hematoxylin-eosin a, x150; b, x 400 
iodules show a mixed population of glial and neuronal cells, with mícmcysts 
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(Prayson et al., 1995). Likewise, the ganglioglioma that 
does not develop within the setting of chronic intractable 
epilepsy has a short duration and may have a more 
aggressive clinical behavior (Prayson et al., 1995). 
Some tumors may be associated with specific 
phakomatoses or inheritable diseases (Lantos et al., 
1997). The ganglioglioma is not associated with any 
specific phakomatosis, but it is associated with neuronal 
migration disorders (in up to 30% of cases) and with 
Down's syndrome, orofaciodigital synostosis and other 
congenital disorders (in about 5% of cases). In contrast, 
the gangliocytoma is associated with Cowden's disease 
and the ganglioneuroma with the familia1 tumor 
syndrome (Lantos et al., 1997). 
b) Histological criteria 
In this group of tumors having a mixed neuronal and 
neuronal-glial component, the cytological characteristics 
of the neurons and of the glia must be assessed 
separately. The neurons may have dysplastic features, 
nuclear atypia and abnormal fonns, which should not be 
interpreted as signs of malignancy, but as degenerative 
changes. The glial component, which sometimes 
undergoes malignant transformation, must be assessed 
according to conventional criteria for glial tumors. 
Among the gangliogliomas, there are recurrent and 
anaplastic tumors, with nuclear and cytological atypia at 
the leve1 of the astrocytic component (Kaba et al., 1996; 
Sasaki et al., 1996; Hakim et al., 1997). Likewise, an 
increase in the proliferative activity of the glial cells 
with specific markers, such as Ki67 (MIBl), is detected 
(Hirose et al., 1997). These histological signs are 
observed in up to 10% of gangliogliomas, appearing 
both in the initial biopsy and in the recurrent lesions, and 
they are associated with a worse prognosis (Hakim et al., 
1997). In fact, the 1993 WHO classification identified 
three grades of ganglioglioma on the basis of cellularity, 
cytological atypias, the presence of necrosis, and 
vascular proliferation. Grade 1 corresponds to the well- 
differentiated tumor; grade 11 includes the ganglioglioma 
having increased cellularity and nuclear pleomorphism; 
and grade 111, those presenting necrosis, numerous 
mitoses and abundant vascular proliferation. There is a 
clear correlation between the cytological degree and 
proliferative activity of a ganglioglioma and the 
prognosis (Wolf et al., 1994). 
Exceptional cases have been reported of atypical 
neurocytoma, with histological evidence of atypia and 
necrosis and proliferative indices that also correlated 
Fig. 8. Meningoangiomatosis. a. The lesion shows areas of the cortex with 
Robin spaces and a mixed gliolieuronal csll population. Hematoxyiin-eosin 
I abundant microcalcifications. b. A striking fibrosis throughout the Virchow- 
x 150 
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with patient survival (Mrark, 1994; Fujimaki et al., 
1997). A few cases of craniospinal dissemination of 
central neurocytoma have been documented (Eng et al., 
1997). It is interesting that some series show an 
incidence of anavlastic transformation in uv to 12% of 
pleomorphic xa~thoastrocytomas (Fig. 5) (perry et al., 
1997). 
Óther classical histological features to be assessed 
include the interface between the tumor and the adjacent 
parenchyma, which is usually clear and the extension of 
the tumor to the leptomeninges and the subarachnoid 
spaces which, in contrast to other brain tumors, is not 
always associated with a worse prognosis (VandenBerg 
et al., 1987; Wolf et al., 1993, 1995; Chintagumpala et 
al., 1996). Two cases of leptomeningeal dissemination 
showing no cytological evidence of malignity have 
recently been reported (Yamamoto et al., 1996; Eng et 
al., 1997). 
c) Immunophenotypic and molecular criteria 
For the correct diagnosis of these lesions, the 
assessment of neuronal and glial differentiation markers 
is usually necessary. It is essential to reflect the 
proliferative activity, since it may be of prognostic 
significance in some types of tumors. In fact, in the 
ganglioglioma (Hirose et al., 1994; Alvarez et al., 1997). 
and the central neurocytoma (Yamamoto et al., 1996), 
the percentage of cells positive for Ki67/MIB1 correlates 
with the probability of local recurrences. However, it is 
important to note that other neuronal tumors, such as the 
dysembryoplastic neuroepithelial tumor, may show a 
high MIBl labeling index, but this does not indicate a 
worse prognosis (Daumas-Duport, 1993). 
The expression of oncogenic proteins such as p53 
has been detected in some gangliogliomas, and this may 
be an indicator of a worse prognosis and a tendency to 
recur (Hirose et al., 1994). Other markers associated 
with a worse prognosis in primitive neuroectodermal 
tumors, such as N-myc amplification, are absent or do 
not indicate a worse prognosis in neuronal tumors. 
Immunoreactivity with E-NCAM may be useful in 
distinguishing hamartias from dysembryoplastic 
neuroepithelial tumors. 
Treatment 
The treatment chosen in al1 these tumors is surgical 
resection. The 5-year survival rate is over 80%. In the 
ganglioglioma, surgical excision is curative. 
Radiotherapy is of questionable utility in grade 11 lesions 
and is recommended in those classified as grade 111, 
given the greater probability of recurrence. It is also 
advisable in those cases in which resection was not 
complete (Wolf et al., 1994; Hakim et al., 1997). It is 
interesting to note that remission in a case of grade 111 
gangliogliorna treated with cis-retinoic acid (Perry et al., 
1997) has been reported. 
In the central neurocytoma, local recurrences are 
absent in 100% of cases in which the tumor was 
completely resected and in 50% to 70% of cases of 
partial resection. In the latter cases, subsequent 
radiotherapy prevented recurrence in up to 100% of 
cases, according to some authors (Fujimaki et al., 1997; 
Perry et al., 1997) with a 5-year survival rate of 88% 
(Nisio et al., 1992; Isimbaldi et al., 1996). 
In dysembryoplastic neuroepithelial tumors, given 
the excellent clinical prognosis and the fact that 
recurrence has not been recorded, radiotherapy and 
chemotherapy are not indicated (Raymond et al., 
1995). 
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